Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview

Loratadine; pseudoephedrine sulfate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for loratadine; pseudoephedrine sulfate and what is the scope of loratadine; pseudoephedrine sulfate freedom to operate?

Loratadine; pseudoephedrine sulfate
is the generic ingredient in three branded drugs marketed by Actavis Labs Fl Inc, Perrigo Pharma Intl, Sun Pharm Inds Ltd, and Bayer Healthcare Llc, and is included in seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-nine drug master file entries for loratadine; pseudoephedrine sulfate. Forty-eight suppliers are listed for this compound.

Summary for Generic Name: loratadine; pseudoephedrine sulfate

Drug Master File Entries: see list39
Suppliers / Packagers: see list48
Clinical Trials: see list298
Drug Prices:see low prices
DailyMed Link:loratadine; pseudoephedrine sulfate at DailyMed

Pharmacology for Ingredient: loratadine; pseudoephedrine sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd
loratadine; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL076557-001Sep 22, 2004OTCNoNo► Subscribe► Subscribe
Bayer Healthcare Llc
loratadine; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL019670-002Nov 27, 2002OTCYesYes► Subscribe► Subscribe
Actavis Labs Fl Inc
loratadine; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL075706-001Feb 21, 2003OTCNoNo► Subscribe► Subscribe
Bayer Healthcare Llc
loratadine; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL020470-002Nov 27, 2002OTCYesYes► Subscribe► Subscribe
Perrigo Pharma Intl
loratadine; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL076050-001Jan 30, 2003OTCNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Formulary management
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus